|
US 12,291,549 B2 |
|
| Farnesoid X receptor modulators |
| Roberto Pellicciari, Perugia (IT); and Antimo Gioiello, Perugia (IT) |
| Assigned to Intercept Pharmaceuticals, Inc., Morristown, NJ (US) |
| Filed by Intercept Pharmaceuticals, Inc., New York, NY (US) |
| Filed on May 14, 2021, as Appl. No. 17/320,286. |
| Application 17/320,286 is a continuation of application No. 15/288,390, filed on Oct. 7, 2016, granted, now 11,034,717. |
| Claims priority of provisional application 62/238,246, filed on Oct. 7, 2015. |
| Prior Publication US 2021/0269475 A1, Sep. 2, 2021 |
| Int. Cl. C07J 31/00 (2006.01); C07J 9/00 (2006.01); C07J 41/00 (2006.01); C07J 43/00 (2006.01); C07J 71/00 (2006.01) |
